Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 47

Daily Deal Round Up: April 12, 2022

Recombinant protein technology provider Healthgen netted over $87m while shared living space provider Hmlet is buying corporate-backed peer Habyt and Uniswap Labs is launching an investment vehicle.

Apr 12, 2022

Exits: April 12, 2022

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Apr 12, 2022

Deals: April 12, 2022

The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

Apr 12, 2022

Viz.ai gets another visit from GV in $100m round

GV returned for the brain scanning technology provider’s series D round at a $1.2bn valuation, boosting its overall funding to about $250m.

Apr 12, 2022

Daily Deal Round Up: April 11, 2022

Creo Capital and Legend Capital helped energy storage system developer MS Energy raise an eight-digit sum while Truora and Medfin each received $15m in corporate-backed rounds.

Apr 11, 2022

Olson exits GV

Jodi Olson has reportedly left Alphabet’s early-stage investment arm, where she had been a communications and marketing partner for roughly a decade.

Apr 11, 2022

BostonGene sequences $150m series B round

The oncology analytics software developer received a top-up from investors including NEC Corporation at a unicorn valuation.

Apr 11, 2022

Triana Biomedicines emerges with $110m

Pfizer Ventures was among the investors in Triana’s series A round and has taken a board seat at the molecular glue platform developer.

Apr 11, 2022

HilleVax to attack public markets

The Takeda spinoff is developing a vaccine for acute gastroenteritis caused by norovirus infection, and raised about $140m in August 2021.

Apr 11, 2022

Daily Deal Round Up: April 8, 2022

Wipro and Intel backed customer experience platform developer Lilt's $55m series C while Pfizer is buying corporate-backed respiratory virus therapeutic developer ReViral for up to $525m.

Apr 8, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here